MedTrace Logo

Impact of Artificial Intelligence-Supported Educational Intervention on Mothers' Fever Management

NCT07086547 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-10-02

No results posted yet for this study

Summary

This study aims to evaluate the effect of an artificial intelligence (AI)-based educational program on mothers' knowledge and anxiety related to fever management in children. Fever is a common symptom in pediatric patients, especially under the age of three, causing repeated health concerns for parents. Despite the prevalence of fever, parents often lack sufficient knowledge and skills to manage it properly, which may lead to unnecessary anxiety and inappropriate care practices.

The study will be conducted as a pretest-posttest experimental design including 80 mothers of children who visit the Pediatric Emergency Clinic at Kayseri City Hospital. Participants will be assigned to either an intervention group receiving AI-supported fever management education or a control group receiving standard care.

Data will be collected using validated scales to assess parental fever management knowledge and anxiety levels before and after the intervention. The educational material was developed using ChatGPT 4.0, a large language model AI platform, and reviewed by pediatric experts.

The results of this study may improve fever management education and reduce anxiety among mothers, potentially leading to better health outcomes for children.

Conditions

  • Fever; Pediatric Fever Management; Parental Anxiety

Interventions

OTHER

AI-Based Fever Management Education

This intervention consists of a fever management education program developed using ChatGPT 4.0, a large language model by OpenAI. The educational content includes seven pages and eight visuals explaining how to manage fever in children. The content was reviewed by pediatric specialists and revised accordingly. It is delivered as a one-time structured session to mothers in the intervention group.

Sponsors & Collaborators

  • ISMIRA JULFAYEVA

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-01
Primary Completion
2025-12-15
Completion
2025-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07086547 on ClinicalTrials.gov